9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2758 | Madecassic acid | 6-Deoxy-L-Galactose,L-Fucose,Brahmic acid,L-fucopyranose | Others , TNF , COX , NO Synthase , Interleukin |
Madecassic acid (L-fucopyranose) is extracted from the whole herb of Centella asiatica. | |||
T82747 | Centellasaponin A | ||
Centellasaponin A (compound 10), a pentacyclic triterpene saponin, has been isolated from the methanolic extract of Centella asiatica [1]. | |||
T2813 | Madecassoside | Asiaticoside A | Apoptosis , Antioxidant , Endogenous Metabolite |
Madecassoside (Asiaticoside A) is a pentacyclic triterpene extracted from Centella asitica (L.) with anti-inflammatory, anti-oxidative and anti-aging activities. | |||
T3025 | Asiaticoside | BRN0078195,CCRIS8995,Emdecassol,Ba 2742,Madecassol,NSC166062 | Apoptosis , p38 MAPK , Reactive Oxygen Species , Endogenous Metabolite , TGF-beta/Smad |
Asiaticoside (Emdecassol) (Madecassol) is the active chemical component of the plant Centella asiatica. Asiaticoside is used to study potential treatments for wounds and burns. | |||
T2827 | Asiatic acid | Asiantic acid,Dammarolic acid | Apoptosis , p38 MAPK , Parasite |
Asiatic acid (Dammarolic acid) is the aglycone of asiaticoside used in wound healing with antioxidant, anti-inflammatory, and neuroprotective properties. | |||
T82042 | Isoasiaticoside | ||
Isoasiaticoside, a pentacyclic triterpene saponin derived from Centella asiatica, exhibits potential neuroprotective effects in the 6-OHDA-induced PC12 cell model [1]. | |||
TMA0778 | 8-Acetoxypentadeca-1,9Z-diene-4,6-diyn-3-ol | Others | |
8-Acetoxypentadeca-1,9Z-diene-4,6-diyn-3-ol is a natural product from Centella asiatica | |||
TMS0879 | Asiaticoside B | Others | |
Asiaticoside B is a triterpene glycoside isolated from Actaea asiatica. It has notable cytotoxicity against HepG2 and MCF-7 cancer cell lines. | |||
T1181 | Gefitinib | ZD1839 | EGFR , Tyrosine Kinases , Autophagy |
Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations. Gefitinib has antitumor activity and is used for the treatment of EGFR-mutated non-small-cell... |